Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
04/2014
04/09/2014EP2716291A1 Combination of opioids and anticancer drugs for cancer treatment
04/09/2014EP2716290A1 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
04/09/2014EP2714905A1 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia
04/09/2014EP2714903A1 Suv39h2 as a target gene for cancer therapy and diagnosis
04/09/2014EP2714892A1 Methods and uses for ex vivo tissue culture systems
04/09/2014EP2714730A1 Novel antigen peptide and uses thereof
04/09/2014EP2714716A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
04/09/2014EP2714703A1 Tricyclic inhibitors of poly(adp-ribose)polymerase
04/09/2014EP2714692A1 Substituted aminoimidazopyridazines
04/09/2014EP2714689A1 Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
04/09/2014EP2714688A1 Heterocyclic compounds as protein kinase inhibitors
04/09/2014EP2714686A1 Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
04/09/2014EP2714685A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
04/09/2014EP2714684A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
04/09/2014EP2714681A1 Substituted sulfonamides useful as antiapoptotic bcl inhibitors
04/09/2014EP2714680A1 Heterocyclic autotaxin inhibitors and uses thereof
04/09/2014EP2714677A1 Pyridine-and pyrazine derivatives
04/09/2014EP2714668A1 Thiazole derivatives
04/09/2014EP2714636A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
04/09/2014EP2714197A1 Combined pharmaceutical compositions for the treatment of tumours
04/09/2014EP2714092A1 Immunoconjugates, compositions containing them, and methods of making and use
04/09/2014EP2714091A2 Modular transport platform for targeted delivery of therapeutic agents
04/09/2014EP2714090A1 Brain tumor targeting peptides and methods
04/09/2014EP2714089A1 Compositions and methods for efficacious and safe delivery of sirna using specific chitosan-based nanocomplexes
04/09/2014EP2714083A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
04/09/2014EP2714078A1 Agents for treating tumours
04/09/2014EP2714073A1 In situ antigen-generating cancer vaccine
04/09/2014EP2714066A1 Soluble protein cd5 or cd6 for the treatment of cancer or tumor or for use as an adjuvant
04/09/2014EP2714065A2 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
04/09/2014EP2714046A1 Methods of treating mesothelioma with a pi3k inhibitor compound
04/09/2014EP2714038A1 Combination therapy of hsp90 inhibitory compounds with mtor/pi3k inhibitors
04/09/2014EP2714033A1 Combination therapy of hsp90 inhibitory compounds with chk inhibitors
04/09/2014EP2714031A1 A synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
04/09/2014EP2714026A2 Modulation of the ubiquitin-proteasome system (ups)
04/09/2014EP2714023A2 Crosslinked polymer nano-assemblies and uses thereof
04/09/2014EP2713727A1 Combination of mek inhibitors and selective inhibitors of aurora a kinase
04/09/2014CN103717740A Pharmaceutical composition for treatment and/or prophylaxis of cancer
04/09/2014CN103717739A Pharmaceutical composition for treatment and/or prophylaxis of cancer
04/09/2014CN103717738A Drug composition for cancer treatment and/or prevention
04/09/2014CN103717737A Cancer treatment and/or prevention drug composition
04/09/2014CN103717735A Technique for cleaving out part of poly(a) chain and/or 3'-terminal sequence of mRNA to inhibit translation reaction
04/09/2014CN103717609A Tricyclic inhibitors of poly(adp-ribose)polymerase
04/09/2014CN103717605A Spiro-oxindole mdm2 antagonists
04/09/2014CN103717604A Substituted aminoimidazopyridazines
04/09/2014CN103717602A Kinase inhibitors
04/09/2014CN103717600A Pyrido-pyrimidine derivatives
04/09/2014CN103717597A Heterocyclic compounds as kinase inhibitors
04/09/2014CN103717595A Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
04/09/2014CN103717591A Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit)
04/09/2014CN103717590A Quinazoline-7-ether compounds and methods of use
04/09/2014CN103717576A Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
04/09/2014CN103717574A Novel compounds and compositions for the inhibition of nampt
04/09/2014CN103717262A Preparation of maytansinoid antibody conjugates by a one-step process
04/09/2014CN103717239A Pharmaceutical composition of oxidized avidin suitable for inhalation
04/09/2014CN103717238A Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
04/09/2014CN103717236A Anti-CD22 antigen binding molecules to treat lung cancer and prostate cancer
04/09/2014CN103717222A Epidithiodioxopiperazines and uses thereof in treating cancer
04/09/2014CN103717221A Method of treating cancer and bone cancer pain
04/09/2014CN103717201A Use of a cb1 receptor antagonist as a whitening and/or anti-browning agent for keratin material
04/09/2014CN103710359A Reoviruses having modified sequences
04/09/2014CN103710311A Cell strain capable of stably secreting and expressing IL-24 recombinant protein, and construction and application thereof
04/09/2014CN103710308A Method for inducing DC-CIK by utilizing muramyl dipeptide
04/09/2014CN103710304A Method for inducing adipose-derived stem cells to differentiate for natural killer cell and purpose thereof
04/09/2014CN103710211A Medlar-mulberry healthcare rice wine and preparation method thereof
04/09/2014CN103709323A Hepatic targeted temperature sensitive microsphere and preparation method therefor
04/09/2014CN103709252A Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same
04/09/2014CN103709251A Human anti-CD26 antibody and applications thereof
04/09/2014CN103709250A Human monoclonal antibodies against CD20
04/09/2014CN103709249A Antibodies and methods for making and using them
04/09/2014CN103709227A Double bond substituted triptolide derivative, and preparation method and applications thereof
04/09/2014CN103709199A Manganese catalase stimulant with high activity as well as preparation method and application thereof
04/09/2014CN103709192A 1,7-Meta-dicarbadecaborane diformic acid-triphenyltin chloride complex, as well as preparation method and application thereof
04/09/2014CN103709172A Substituted furan-piperidine derivative and application thereof
04/09/2014CN103709162A Tri-substituted imidazo diazanaphthalene ketone compounds, preparation method thereof and applications thereof
04/09/2014CN103709156A Dasatinib polymorph medicine and preparation method thereof
04/09/2014CN103709147A Flumatinib mesylate crystal form, preparation method thereof and applications thereof
04/09/2014CN103709146A Quinoline-4-amine derivatives containing benzimidazole structure, as well as preparation method and medical use thereof
04/09/2014CN103709145A Quinolines compound containing hexahydropyrimidone as well as preparation method and application thereof
04/09/2014CN103709138A 5-(fluoroquinolone C3- methylene)3-pyrrolic amide derivative as well as preparation method and application thereof
04/09/2014CN103709135A Xanthone derivative and preparation method and application thereof
04/09/2014CN103709122A Antitumor and antifungal compound for treatment
04/09/2014CN103709096A Urea type derivative used as nicotinamide ribose phosphate transferase inhibitor, as well as preparation method and application thereof
04/09/2014CN103709094A 4-phenoxy benzamide compound as well as preparation method and application thereof
04/09/2014CN103709052A Rhein amino-alcohol ester type compound, and preparation method and pharmaceutical application thereof
04/09/2014CN103709015A Application of ginkgol C17:1 in treatment of liver cancer
04/09/2014CN103705944A Preparation method and application of folic acid-modified nano-diamond targeting medicine
04/09/2014CN103705943A Preparation method and application of reduction-response-type pegylation (PEG) nanomedicine composition
04/09/2014CN103705940A Preparation and anti-tumor application of natural active drug-polysaccharide targeted compound
04/09/2014CN103705939A Preparation of amphiphilic ursolic acid-polysaccharide coupled substance and application thereof in treating tumors
04/09/2014CN103705936A Preparation method of fish collagen double sustained-release film
04/09/2014CN103705934A Polypeptide modified brain glioma targeted medicine delivery system
04/09/2014CN103705931A Shell-droppable polymer nano carrier as well as preparation method and application thereof
04/09/2014CN103705928A Single-layer MoS2 nano-chip, preparation method and nano-drug carrier
04/09/2014CN103705926A Pharmaceutical composition used for preventing primary tumor metastasis after exairesis
04/09/2014CN103705925A Medicine composition and method for inhibiting PI3K/AKT/mTOR signaling pathways
04/09/2014CN103705924A Combined application of miR-1255a and tumor treating medicine
04/09/2014CN103705923A Method and reagent used for inhibiting tumor metastasis
04/09/2014CN103705921A Methods for treating conditions associated with MASP-2 dependent complement activation
04/09/2014CN103705920A Cytoplasmic polyadenylation element-binding protein 4 vaccine, and preparation and application thereof
04/09/2014CN103705915A Rhamnose modified tumor whole-cell vaccine
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 2211